Your browser doesn't support javascript.
Retrospective Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in Symptomatic Patients Prior to Widespread Diagnostic Testing in Southern California.
Hilt, Evann E; Boocock, James; Trejo, Marisol; Le, Catherine Q; Guo, Longhua; Zhang, Yi; Sathe, Laila; Arboleda, Valerie A; Yin, Yi; Bloom, Joshua S; Wang, Pin-Chieh; Elmore, Joann G; Kruglyak, Leonid; Shrestha, Lasata; Bakhash, Shah A Mohamed; Lin, Michelle; Xie, Hong; Huang, Meei-Li; Roychoudhury, Pavitra; Greninger, Alexander; Chandrasekaran, Sukantha; Yang, Shangxin; Garner, Omai B.
  • Hilt EE; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA.
  • Boocock J; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Trejo M; Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Le CQ; Howard Hughes Medical Institute, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Guo L; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA.
  • Zhang Y; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA.
  • Sathe L; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Arboleda VA; Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Yin Y; Howard Hughes Medical Institute, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Bloom JS; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Wang PC; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA.
  • Elmore JG; Department of Pathology & Laboratory Medicine, David Geffen School of Medicine, University of California Los Angeles (UCLA), Los Angeles, California, USA.
  • Kruglyak L; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Shrestha L; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Bakhash SAM; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Lin M; Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Xie H; Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Huang ML; Department of Medicine, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Roychoudhury P; Department of Human Genetics, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Greninger A; Department of Biological Chemistry, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Chandrasekaran S; Howard Hughes Medical Institute, David Geffen School of Medicine, UCLA, Los Angeles, California, USA.
  • Yang S; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
  • Garner OB; Department of Laboratory Medicine, University of Washington Medical Center, Seattle, Washington, USA.
Clin Infect Dis ; 74(2): 271-277, 2022 01 29.
Artículo en Inglés | MEDLINE | ID: covidwho-1662113
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused one of the worst pandemics in recent history. Few reports have revealed that SARS-CoV-2 was spreading in the United States as early as the end of January. In this study, we aimed to determine if SARS-CoV-2 had been circulating in the Los Angeles (LA) area at a time when access to diagnostic testing for coronavirus disease 2019 (COVID-19) was severely limited.

METHODS:

We used a pooling strategy to look for SARS-CoV-2 in remnant respiratory samples submitted for regular respiratory pathogen testing from symptomatic patients from November 2019 to early March 2020. We then performed sequencing on the positive samples.

RESULTS:

We detected SARS-CoV-2 in 7 specimens from 6 patients, dating back to mid-January. The earliest positive patient, with a sample collected on January 13, 2020 had no relevant travel history but did have a sibling with similar symptoms. Sequencing of these SARS-CoV-2 genomes revealed that the virus was introduced into the LA area from both domestic and international sources as early as January.

CONCLUSIONS:

We present strong evidence of community spread of SARS-CoV-2 in the LA area well before widespread diagnostic testing was being performed in early 2020. These genomic data demonstrate that SARS-CoV-2 was being introduced into Los Angeles County from both international and domestic sources in January 2020.
Asunto(s)
Palabras clave

Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Clin Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: Cid

Similares

MEDLINE

...
LILACS

LIS


Texto completo: Disponible Colección: Bases de datos internacionales Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Estudios diagnósticos / Estudio observacional / Estudio pronóstico Límite: Humanos País/Región como asunto: America del Norte Idioma: Inglés Revista: Clin Infect Dis Asunto de la revista: Enfermedades Transmisibles Año: 2022 Tipo del documento: Artículo País de afiliación: Cid